73 related articles for article (PubMed ID: 520386)
21. A controlled double-blind study of high-dose dihydroergotoxine mesylate (Hydergine) in mild dementia.
Thienhaus OJ; Wheeler BG; Simon S; Zemlan FP; Hartford JT
J Am Geriatr Soc; 1987 Mar; 35(3):219-23. PubMed ID: 3819261
[TBL] [Abstract][Full Text] [Related]
22. Pharmacotherapy for organic brain syndrome in late life. Evaluation of an ergot derivative vs placebo.
Gaitz CM; Varner RV; Overall JE
Arch Gen Psychiatry; 1977 Jul; 34(7):839-45. PubMed ID: 406875
[TBL] [Abstract][Full Text] [Related]
23. [Inhibition of post-partum physiological milk secretion by caffeine dihydroergocryptine and dihydroergotoxine].
Elsener M; Ferrafiat M; de Bruyn M; Jouhet P; Robert Y; Rouge PE
Rev Fr Gynecol Obstet; 1988 Nov; 83(11):697-701. PubMed ID: 3144727
[TBL] [Abstract][Full Text] [Related]
24. [Therapy of organic brain syndrome with nicergoline given once a day].
Ladurner G; Erhart P; Erhart C; Scheiber V
Wien Klin Wochenschr; 1991; 103(1):8-14. PubMed ID: 2014712
[TBL] [Abstract][Full Text] [Related]
25. Effects of dopaminergic agonists and antagonists on the serum prolactin levels in alcoholized rats.
Samochowiec J; Kleinrok Z; Jagiełło-Wójtowicz E; Horodnicki J; Rommelspacher H; Schmidt LG
Pol J Pharmacol; 1997 Aug; 49(4):221-7. PubMed ID: 9437765
[TBL] [Abstract][Full Text] [Related]
26. [One-year therapy with dihydroergocristine for treatment of impaired alertness and memory in elderly patients. Placebo-controlled multicenter study].
Agliati G; Lazzaroni M; Mariani G; Marras F; Massetto N; Menozzi C; Ortenzi E; Perna G; Puppo N; Santambrogio S
Arzneimittelforschung; 1992 Nov; 42(11A):1414-6. PubMed ID: 1492865
[TBL] [Abstract][Full Text] [Related]
27. The treatment of senile dementia associated with cerebrovascular insufficiency: a comparative study of buflomedil and dihydrogenated ergot alkaloids.
Jansen W; Bruckner GW; Jansen P
J Int Med Res; 1985; 13(1):48-53. PubMed ID: 3884411
[TBL] [Abstract][Full Text] [Related]
28. Controlled study of dihydroergotoxine in gerontopsychiatric patients.
Slánská J
Act Nerv Super (Praha); 1989 Apr; 31(1):53-5. PubMed ID: 2782002
[No Abstract] [Full Text] [Related]
29. Mental decline in the elderly: pharmacotherapy (ergot alkaloids versus papaverine).
Rosen HJ
J Am Geriatr Soc; 1975 Apr; 23(4):169-74. PubMed ID: 803997
[TBL] [Abstract][Full Text] [Related]
30. [The effect of several sexual steroids, 2-bromo-ergokryptin and lisurid-hydrogenmaleate an the postpartum concentration of serum prolactin and lactation (author's transl)].
Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; Michel E; Nevinny-Stickel J
Geburtshilfe Frauenheilkd; 1977 Jun; 37(6):500-8. PubMed ID: 328335
[TBL] [Abstract][Full Text] [Related]
31. [Nicardipine in the therapy of arterial hypertension in elderly patients with the psycho-organic syndrome. Report on the results of the clinical study].
Scarzella L; Bergamasco B
Clin Ter; 1989 Aug 15-31; 130(3-4):171-8. PubMed ID: 2529091
[TBL] [Abstract][Full Text] [Related]
32. Reproductive toxicity of ergot alkaloids in mink.
Sharma C; Aulerich RJ; Render JA; Reimers T; Rottinghaus GE; Kizilkaya K; Bursian SJ
Vet Hum Toxicol; 2002 Dec; 44(6):324-7. PubMed ID: 12458632
[TBL] [Abstract][Full Text] [Related]
33. [Prolactin in the alcohol withdrawal syndrome. Role of the dopaminergic system].
Nardoni A; Marchetti E; Geatti O; Di Piazza V; Rossi G
Minerva Med; 1984 Dec; 75(47-48):2833-8. PubMed ID: 6521953
[TBL] [Abstract][Full Text] [Related]
34. [A new view of the evaluation of alcohol withdrawal and alcohol dependence].
Samochowiec J; Horodnicki J
Psychiatr Pol; 1995; 29(1):139-49. PubMed ID: 7878150
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of xantinolnicotinate in patients with dementia.
Kanowski S; Fischhof PK; Grobe-Einsler R; Wagner G; Litschauer G
Pharmacopsychiatry; 1990 May; 23(3):118-24. PubMed ID: 2197635
[TBL] [Abstract][Full Text] [Related]
36. Double-blind study of thioridazine and haloperidol in geriatric patients with a psychosis associated with organic brain syndrome.
Cowley LM; Glen RS
J Clin Psychiatry; 1979 Oct; 40(10):411-9. PubMed ID: 489517
[TBL] [Abstract][Full Text] [Related]
37. [Psychopathologic changes in chronic schizophrenic patients following withdrawal of neuroleptics: relation to therapeutic, neuroendocrine and computer tomography variables].
Albus M; Naber D; Ackenheil M; Bürke H; Müller-Spahn F; Münch U; Reinertshofer T; Schmidt-Vanderheyden W; Weber G; Wissmann J
Fortschr Neurol Psychiatr; 1986 Jan; 54(1):15-20. PubMed ID: 2868983
[TBL] [Abstract][Full Text] [Related]
38. Single-case study of clinical response to high-dose ergot alkaloid treatment for dementia. Preliminary report.
Yesavage JA; Tinklenberg JR
Gerontology; 1981; 27(1-2):76-8. PubMed ID: 7215823
[No Abstract] [Full Text] [Related]
39. Hydergine helpful for Alzheimer's disease.
Geriatrics; 1979 Oct; 34(10):23. PubMed ID: 478308
[No Abstract] [Full Text] [Related]
40. The clinical assessment of brain failure in the elderly.
McConnachie RW
Pharmacology; 1978; 16 Suppl 1():27-35. PubMed ID: 347464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
